Viking Holdings' 2025 Nearly Sold Out, But Goldman Sachs Seeks More Pricing Clarity For 2026
Goldman Sachs analyst Lizzie Dove reiterated a Neutral rating on the shares of Viking Holdings Ltd (NYSE:VIK) and raised the ...
This tiny South Jersey town has built stunning boats for 60 years at Viking Yachts
In 1990, Viking sold 90 boats. When the tax went into effect, sales dropped to 32. A year later, the company sold just 12 ...
Yahoo Finance3d
Viking strikes $150m deal to secure supply of obesity drug
Viking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its investigational obesity drug, VK2735, as the biotech positions itself to ...
Seeking Alpha1mon
Viking Holdings' Competitive Position Comes At A Price
In Q3, Viking had $90 million in interest expenses, making the company’s interest rate 7.11% with the current amount of interest-bearing debt. I estimate a fair 25% long-term debt-to-equity ratio.
ETF Daily News28d
Sumitomo Mitsui Trust Group Inc. Has $1.90 Million Stock Position in Viking Holdings Ltd (NYSE:VIK)
Sumitomo Mitsui Trust Group Inc. grew its position in shares of Viking Holdings Ltd (NYSE:VIK – Free Report) by 9.6% in the fourth quarter, HoldingsChannel reports.The fund owned 43,088 shares ...
The Motley Fool18d
Wall Street Thinks This Weight Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk
Analysts are bullish about Viking Therapeutics. Wall Street likes the company's promising pipeline, especially lead candidate VK-2735. Aggressive investors could find Viking Therapeutics stock ...